Home  »  Companies   »  New Big Money Means AVEO Pharmaceuticals Inc. (AVE...

New Big Money Means AVEO Pharmaceuticals Inc. (AVEO) Investors Could Reap Benefit

AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) is 216.84% higher on its value in year-to-date trading and has touched a low of $3.06 and a high of $14.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AVEO stock was last observed hovering at around $14.85 in the last trading session, with the day’s gains setting it 0.01% off its average median price target of $15.00 for the next 12 months. It is also 0.93% off the consensus price target high of $15.00 offered by analysts, but current levels are 0.93% higher than the price target low of $15.00 for the same period.

Currently trading at $14.86, the stock is 0.39% and 26.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing 0.07% at the moment leaves the stock 107.02% off its SMA200. AVEO registered 132.55% gain for a year compared to 6-month gain of 282.01%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 0.58% loss in the last 1 month and extending the period to 3 months gives it a 81.88%, and is 0.20% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.23% over the week and 0.38% over the month.

AVEO Pharmaceuticals Inc. (AVEO) has around 115 employees, a market worth around $516.24M and $94.30M in sales. Fwd P/E is 27.67. Profit margin for the company is -30.80%. Distance from 52-week low is 385.62% and -0.60% from its 52-week high.

AVEO Pharmaceuticals Inc. (AVEO) Analyst Forecasts

AVEO Pharmaceuticals Inc. is expected to release its quarterly report on 03/14/2023.The EPS is expected to grow by 1.80% this year

AVEO Pharmaceuticals Inc. (AVEO) Top Institutional Holders

The shares outstanding are 34.62M, and float is at 33.72M with Short Float at 1.89%.

AVEO Pharmaceuticals Inc. (AVEO) Insider Activity

A total of 0 insider transactions have happened at AVEO Pharmaceuticals Inc. (AVEO) in the last six months, with sales accounting for 0 and purchases happening 0 times.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.